GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New cancer drug begins human testing for multiple advanced tumors

Disease control Not yet recruiting

This is the first study in humans testing a new cancer drug called QLS5316. Researchers want to find the safest dose and see if it helps control advanced solid tumors in patients who have run out of standard treatment options. The study will enroll 300 adults with various advance…

Matched conditions: GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Apr 02, 2026 00:57 UTC

GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new GASTRIC CANCER OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

New cancer drug begins human testing for multiple advanced tumors